Fig. 01 -

Title Slide

Fig. 02 -

Disclosures

Fig. 03 -

To Discuss

Fig. 04 -

Recurrent Episodes

Fig. 05 -

Reduction

Fig. 06 -

Metric of Severity

Fig. 07 -

Crowded Upper Airway

Fig. 08 -

Sleep Disruption Flow

Fig. 09 -

OSA

Fig. 10 -

Who’s at risk?

Fig. 11 -

To Discuss (cont)

Fig. 12 -

Management

Fig. 13 -

Daily Functioning

Fig. 14 -

FOSQ Figures

Fig. 15 -

Results

Fig. 16 -

Management

Fig. 17 -

Optimal Use

Fig. 18 -

Utilization

Fig. 19 -

Positional Therapy

Fig. 20 -

Biopsychosocial Model

Fig. 21 -

Sleep-Disordered Breathing

Fig. 22 -

28 Days

Fig. 23 -

Follow Up

Fig. 24 -

Adherence

Fig. 25 -

Troubleshooting

Fig. 26 -

Residual Sleepiness

Fig. 27 -

Neuronal Injury

Fig. 28 -

Brain White Matter

Fig. 29 -

Epworth and Psychomotor

Fig. 30 -

Efficacy of Modafinil

Fig. 31 -

Appliance vs Surgery

Fig. 32 -

Take Home Message

Fig. 33 -

Thank You